Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermatopharmacokinetic Trial of LEO 90100 Foam
NCT03476746Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of calcipotriol in plaque psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoints: Amount of calcipotriol in the stratum corneum at 24 hours and Amount of betamethasone dipropionate in the stratum corneum at 24 hours. Started Mar 2018; status: completed.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03476746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476746.